Replies to post #225464 on Biotech Values

[DewDiligence]

MACK announces Section-232 rights plan to protect economic value of NOLs:

https://www.businesswire.com/news/home/20191203005646/en

I don’t understand the legal technicalities of such a plan. Perhaps one of the lawyers on this board will chime in.

[DewDiligence]

MACK seeks shareholder approval to dissolve—with liquidating dividend based on Onivyde milestone payment from Ipsen:

https://finance.yahoo.com/news/merrimack-reports-ipsen-announcement-approval-211800921.html

MACK has been a shell company with a potential milestone payment since ceasing operations almost five years ago (#msg-149704592).